Anticoagulation and Prosthetic Heart Valves

  • E. M. Baudet
Conference paper


According to the Munich Terminology (1) the term prosthetic valve is synonymous with mechanical or artificial valves. Nevertheless, prosthetic valves concern not only mechanical valves but also porcine and pericardial bioprostheses (xenografts).


Valve Replacement Prosthetic Valve Mitral Valve Replacement Mechanical Valve Prosthetic Heart Valve 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sebening F, Klövekorn WP, Meisner H et al (eds) (1979) Bioprosthetic Cardiac Valves: Proceedings of the First International Symposium on Tissue Heart Valves. Munich, April 5–7. Deutsches Herzzentrum MünchenGoogle Scholar
  2. 2.
    Chesebro JM, Fuster V, Elveback LR et al (1983) Trial of combined warfarin plus dipyridamole or aspirin therapy in prosthetic heart valve replacement: Danger of aspirin compared with dipyridamole. Am J Cardiol 51: 1537PubMedCrossRefGoogle Scholar
  3. 3.
    Avellaneda A (1983) Les accidents thrombo-emboliques et neuropsychiatriques et leur incidence à court et long terme chez les porteurs de prothèses valvulaires cardiaques. Thèse de Doctorat en Médécine, n° 143, BordeauxGoogle Scholar
  4. 4.
    Chakrabarti R, Hocking ED, Fearnley GR (1976) Reaction pattern to three stresses: electroplexy, surgery and myocardial infarction of fibrinolysis and plasma fibrinogen. J Clin Pathol 22: 659–662CrossRefGoogle Scholar
  5. 5.
    Fulton RM, Duckett, K (1976) Plasma fibrinogen and thromboemboli after myocardial infarction. Lancet 2: 1161PubMedCrossRefGoogle Scholar
  6. 6.
    Cohn LH, Gallucci V (1982) Cardiac Bioprostheses: Proceedings of the Second International Symposium on Tissue Heart Valves. Rome, May 17–19. Yorke Medical Books, New YorkGoogle Scholar
  7. 7.
    Limet R, Lepage G, Grondin CM (1977) Thromboembolic complications with the cloth-covered Starr-Edwards aortic prosthesis in patients not receiving anticoagulants. Ann Thorc Surg 23: 529CrossRefGoogle Scholar
  8. 8.
    St John Sutton MG, Miller GAH, Oldershaw PJ et al (1978) Anticoagulants and the Björk-Shiley prosthesis. Experience of 390 patients. Br Heart J 40: 558PubMedCrossRefGoogle Scholar
  9. 9.
    Baudet EM, Oca CC, Roques FX et al (1984) Five and half year’s experience with the St. Jude Medical cardiac valve prosthesis: Early and late results of 737 valve replacements in 671 patients. Fourth International Symposium on the St. Jude Medical Valve, Montego Bay, Jamaica, March 12–14 (in press)Google Scholar
  10. 10.
    Edmunds LH Jr (1982) Thromboembolic complications of current cardiac valvular prostheses. Ann Thorac Surg 34: 96PubMedCrossRefGoogle Scholar
  11. 11.
    Baudet EM (1983) Management of early anticoagulant therapy after valve replacement. Simposio Internationale sulle Malattie Valvolari Cardiache Acquisite, Acireale — Catania (Sicily), June 20–23. Acta Mediterranea (in press)Google Scholar
  12. 12.
    Wells RE, Gawronski TH, Cox PJ et al (1964) Influence of fibrinogen on flow properties of erythrocytes suspensions. Am J Physiol 207: 1035PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1986

Authors and Affiliations

  • E. M. Baudet
    • 1
  1. 1.Dept. of Cardiovascular SurgeryHopital CardiologiqueBordeauxFrance

Personalised recommendations